rTMS-primed self-controlled practice for people with Parkinson’s disease
Official title: Effects of Repetitive Transcranial Magnetic Stimulation (rTMS)-Primed Self-controlled Practice on Motor Behavior, Psychosocial Functioning, and Neurophysiological Mechanisms in People With Parkinson's Disease
Run by National Taiwan University Hospital · NCT07832695 · Data updated 2026-11-12
This study tests whether priming motor training with rTMS and letting people with Parkinson’s control their practice improves motor learning and motivation.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | National Taiwan University Hospital Academic / other |
| Locations | 1 site (Taipei, Zhongzheng Dist.) |
| Status | Recruiting |
| Started | September 23, 2026 |
| Main results expected | December 31, 2031 |
| Study ends | December 31, 2032 |
| Registry record updated | September 22, 2026 |
| Trial ID | NCT07832695 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with Parkinson’s disease who can stand/walk for 10 minutes and have Montreal Cognitive Assessment score ≥ 24.
✕Probably not a fit
Patients with contraindications to TMS or unstable medical conditions, or those unable to follow study instructions, may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study explores whether combining repetitive transcranial magnetic stimulation (rTMS) with self-controlled motor training enhances rehabilitation outcomes in Parkinson’s disease. Participants will receive rTMS priming before or during physical therapy that allows self-selected training parameters, aiming to improve motor learning and engagement. The trial investigates whether targeting different cortical areas yields different benefits and whether the approach is feasible in an outpatient setting. Eligible adults with Parkinson’s disease must be able to stand/walk for 10 minutes and have adequate cognitive function. Safety considerations include exclusion of individuals with contraindications to TMS or other neurological/medical conditions that could confound results.
Why it matters
Potential benefit: If successful, patients may experience better motor learning, greater motivation, and improved rehabilitation responses.
How similar studies have gone: Previous evidence supports using self-controlled training and neuromodulation to boost motor learning, though combining rTMS priming with self-controlled practice is still being explored.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * diagnosed of PD by neurologists and age above 18 years old * able to follow the researcher's instruction (the Montreal Cognitive Assessment ≥ 24) * able to stand and walk independently for 10 minutes with or without assistive devices Exclusion Criteria: * have neurological disorders other than PD (e.g., Parkinson plus syndrome, cognitive impairment, dementia, stroke) * have contraindications to receive TMS, such as a pacemaker or deep brain stimulator implanted in the body * a self-history of seizure or a family history of epilepsy * pregnancy * unstable medical conditions that is not under control
Where it's running
-
School and Graduate Institute of Physical Therapy
Taipei, Zhongzheng Dist., Taiwan Recruiting
Study contacts
- Principal investigator: Graduate Institute of Physical Therapy — National Taiwan University
- Study coordinator: Ya-Yun Lee, PhD
- Email: yayunlee@ntu.edu.tw
- Phone: +886-2-33668155
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Parkinson’s Risk in Gaucher Disease Type 1
This study tests how Parkinson’s risk relates to GBA1-related Gaucher disease in adults over 40, by collecting detailed clinical data and samples for future research.
-
Can the Ronnie Gardiner Method improve thinking and daily function in people with Parkinson’s
In this 10-week program, adults with Parkinson’s disease will try the Ronnie Gardiner Method to see if it helps thinking, talking, movement, balance, and quality of life.
-
Effects of excitatory and inhibitory LIFUS of GPi in Parkinson’s patients without DBS
This study tests two deep-brain focused ultrasound patterns on people with Parkinson’s to see if they change task performance and tremor, compared with a sham stimulation.
-
Capacitive-resistive radiofrequency therapy for people with Parkinson's disease
This study tests four TECAR therapy protocols on the legs to see which best reduces muscle stiffness and improves walking in people with Parkinson's disease.
-
TRB-001 safety and immune response in early Parkinson's disease
This early-phase study tests TRB-001 against placebo to see if it is safe and prompts an immune response in people with recently diagnosed Parkinson’s disease.
-
Bayesian optimization to tune DBS for better gait in Parkinson’s patients
This study tests whether using Bayesian optimization can quickly find DBS settings that lengthen step length in people with Parkinson's who already have DBS in place.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.